Jiangsu Ruike Pharmaceutical Technology Co., Ltd announced that it will receive CNY 300,000,000 in an equity round of funding on April 20, 2017. The transaction will include participation from returning investor Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHSE:603456) to maintain its 100% stake in the company after the transaction. The transaction was approved at the 20th session of the 5th directorate of the investor and does not need its shareholders’ approval. The amount of CNY 90,625,000 will be added to the registered capital and remaining to the capital reserve The registered capital of the company will increase from CNY 209,375,500 to CNY 300,000,000. The company reported total assets of CNY 705,236,000, net assets of CNY 94,394,300, net profit of –CNY 43,558,400, and revenues of CNY 261,109,000 for the year ended December 31, 2016.